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Tuesday, March 1, 2016 397aHere, we describe discovery of two small molecules which specifically enhance
catalytic efficiency of peptidase neurolysin. A computational approach was
used to explore structure of neurolysin and identify a druggable surface pocket
in its hinge region, followed by docking and ranking of 139,735 molecules from
NCI DTP database. Top ranking compounds were subjected to pharmacolog-
ical evaluation. Two structurally related compounds were identified which
enhanced the rate of substrate hydrolysis by recombinant (human and rat)
and mouse brain-purified neurolysins in a concentration-dependent manner.
Neither the identified modulators nor dynorphin A(1-13), a competitive inhib-
itor, affected each other’s affinity in modulating activity of neurolysin, suggest-
ing that the modulators do not bind to the substrate binding site. Both
modulators reduced Km and increased Vmax values for hydrolysis of the syn-
thetic substrate by neurolysin in a concentration-dependent manner. The mod-
ulators had negligible effect on catalytic activity of thimet oligopeptidase,
neprilysin, angiotensin converting enzyme (ACE) and ACE2, indicating that
they are specific to neurolysin. Both modulators also enhanced hydrolysis of
endogenous substrates, suggesting that their effect was not linked to the syn-
thetic substrate. The identified molecules could be developed into research
tools for evaluation of the (patho)physiological function of neurolysin. This
study is one of few utilizing a structure-based approach for rational identifica-
tion of enzyme activators, and by that it demonstrates applicability of this meth-
odology for identification of allosteric modulators of other enzymes.
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Phenotypes by Single Molecule Studies
Matias E. Moses1, Sara Thodberg2, Krutika Bavishi2, Stine Eiersholt1,
Darui Li1, Dimitrios Stamou1, Birger L. Moller2, Tomas Laursen2,
Nikos S. Hatzakis1.
1Chemistry, Nanoscience Center University of Copenhagen, Copenhagen,
Denmark, 2Plant and Environmental sciences, Plant Biochemistry,
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The dynamic exploration of conformational states, also termed conformational
sampling, is known to govern all aspects of protein behavior from folding to
function. The way however it encodes enzyme function - the capacity to accel-
erate the chemical step and plasticity of accepting structurally diverse sub-
strates - are terra incognita for conventional bulk characterization but can be
directly observed by single molecule studies(1-3).
To interrogate the functional and structural dynamics of individual enzymes we
spatially confine them on arrays of native membrane like systems (liposomes or
nanodiscs)(4). In addition to providing a native like environment - minimizing
deleterious interactions with hard matter, these systems may act as 3D scaffold
for the assembly of multiple regulatory bioelements. Our parallel single mole-
cule readout allows us to directly observe, and quantify the extend of confor-
mational sampling for multiple enzymes (P450 oxidoreductases and lipases)
and consequently its dependence on regulatory inputs and mutations(5-7).
Comparing the readouts on wild type enzymes with their pathogenic mutants
with varying plasticity provides the intricate correlation between extends of
conformational sampling and plasticity. Providing the first clues of conforma-
tional sampling acting as cue for functional and consequently clinical pheno-
type may pave the way for controlling plasticity and the de novo design of
proteins with tailor made functionalities.
1. N. S. Hatzakis, Biophys. Chem. 186, 46 (2014).
2. T. Ha, Nat Meth 11, 1015 (2014).
3. M. F. Juette et al., Curr. Opin. Chem. Biol. 20, 103 (Jun, 2014).
4. N. S. Hatzakis et al., Nat. Chem. Biol. 5, 835 (Nov, 2009).
5. N. S. Hatzakis et al., J. Am. Chem. Soc. 134, 9296 (Jun, 2012).
6. K. Bavishi, N. S. Hatzakis, Molecules 19, 19407 (Dec, 2014).
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Quantifying the Molecular Constraints Driving the Trimethoprim Resis-
tance in Escherichia Coli
Yusuf T. Tamer.
Molecular Biophysics, UT Southwestern, Dallas, TX, USA.
Trimethoprim (TMP) is an antibiotic molecule that blocks nucleic acid synthe-
sis by competitively binding to the dihydrofolate reductase (DHFR) enzyme
[1]. We have previously identified DHFR mutations and the order they appear
over the course of trimethoprim resistance evolution [2]. We have purified and
characterized DHFR mutants that have up to five point mutations. For every
mutant DHFR, we quantified trimethoprim affinity (Ki) and catalytic power
(Kcat/Km). We quantify epistatic interactions between resistance conferring
mutations and the trade-offs between mutant proteins’ catalytic powers and
trimethoprim affinities [3]. Finally, we explain why some mutations appear
earlier in the course of evolution.1. Schnell, J.R., H.J. Dyson, and P.E. Wright, Structure, dynamics, and cata-
lytic function of dihydrofolate reductase. Annu Rev Biophys Biomol Struct,
2004. 33: p. 119-40.
2. Toprak, E., et al., Evolutionary paths to antibiotic resistance under dynam-
ically sustained drug selection. Nat Genet, 2012. 44(1): p. 101-5.
3. Palmer, A.C., et al., Delayed commitment to evolutionary fate in antibiotic
resistance fitness landscapes. Nat Commun, 2015. 6: p. 7385.
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Edward N. Janoff2, Elan Z. Eisenmesser1.
1Biochemistry and Molecular Genetics, University of Colorado Denver
Anschutz medical campus, Aurora, CO, USA, 2Division of Infectious
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Streptococcus pneumoniae (SPN) is a gram-positive bacterium which causes
non-invasive infections, such as otitis media, as well as invasive diseases
like pneumonia and meningitis. Despite the development of bacterial antibi-
otics and vaccines, exposure to SPN still leads to diseases in young, elderly,
and immunocompromised individuals. Current vaccines have serious limita-
tions due to the serotype variability and genomic plasticity of the bacterium
and therefore, an ever-increasing frequency of multidrug-resistant strains
have been reported. Immunoglobulin A1 (IgA1) represents 90% of the IgA
within the human respiratory tract and multiple bacterial pathogens, including
SPN, can produce an IgA1-specific protease (IgA1P) to inactivate this major
component of mucosal immunity. IgA1P cleaves IgA1 at the hinge region
and leads to removal of the Fc domain of IgA1, which is recognized by host
clearance mechanisms. Because of the universal expression among different se-
rotypes of SPN, IgA1P has been shown to be a potential target for new vaccine
development. SPN IgA1P is unique with no sequence conservation to any other
known protein, other than a conserved HExxH Zn-binding motif found in many
metalloproteases. We have discovered that the SPN IgA1P released from cells
is active and our biochemical studies have revealed that the SPN IgA1P con-
tains a well-folded C-terminal domain (CTD) that houses the third Zn coordi-
nating residue, Glu1628. Furthermore, our data illustrates that the N-terminal
domain (NTD) is primarily responsible for engaging IgA1 and the CTD does
not have detectable affinity for IgA1 by itself. However, the CTD does play
a role in facilitating the binding and is essential for the catalytic activity. Our
discoveries shed light on the mechanistic details of this novel metalloprotease
and potentially help in developing better vaccines.
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Pressure Modulation of the Enzymatic Activity of Phospholipase A2 - a
Putative Membrane-Associated Pressure Sensor
Saba Suladze, Roland Winter.
TU Dortmund University, Dortmund, Germany.
Phospholipases A2 (PLA2) catalyze the hydrolysis reaction of sn-2 fatty acids
of membrane phospholipids and are involved in inflammatory responses to
many neurodegenerative diseases through participation in receptor signaling
and transcriptional pathways. We used pressure modulation of the PLA2 activ-
ity and of the membrane’s physical-chemical properties to reveal new mecha-
nistic information on the membrane association and subsequent enzymatic
reaction (1). Although the effect of high hydrostatic pressure on soluble and in-
tegral membrane proteins has been investigated to some extent, its effect on
enzymatic reactions operating at the water/lipid interface has not been
explored, yet. This study focuses on the effect of pressure on the structure,
membrane binding and activity of membrane-associated PLA2. To this end,
high-pressure FTIR spectroscopy and high-pressure stopped-flow fluorescence
spectroscopies were applied. The results show that PLA2 binding to model
membranes is not significantly affected by pressure and occurs in at least
two kinetically distinct steps. Followed by fast initial membrane association,
structural reorganization of helical segments of PLA2 takes place at the lipid
water interface. FRET-based activity measurements reveal that pressure has
an inhibitory effect on the lipid hydrolysis rate. The reduced activity is due
to a stronger compression of the enzyme-substrate complex in comparison to
that of the transition state. Additionally, a decrease in membrane fluidity
upon compression impedes conformational changes accompanying various re-
action steps, thereby reducing the rate of the overall reaction. Our results pro-
vide novel information regarding molecular interactions in the course of PLA2
binding and lipid hydrolysis, and are important for understanding how such en-
zymes function under extreme environmental conditions, such as those in the
deep sea where pressures up to the kbar-level are encountered.
(1) Suladze S.; Winter R.; J. Am. Chem. Soc. 2015, in press.
